1. Home
  2. VIR vs TIXT Comparison

VIR vs TIXT Comparison

Compare VIR & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • TIXT
  • Stock Information
  • Founded
  • VIR 2016
  • TIXT 2005
  • Country
  • VIR United States
  • TIXT Canada
  • Employees
  • VIR N/A
  • TIXT N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • TIXT EDP Services
  • Sector
  • VIR Health Care
  • TIXT Technology
  • Exchange
  • VIR Nasdaq
  • TIXT Nasdaq
  • Market Cap
  • VIR 1.0B
  • TIXT 1.0B
  • IPO Year
  • VIR 2019
  • TIXT 2021
  • Fundamental
  • Price
  • VIR $9.28
  • TIXT $3.77
  • Analyst Decision
  • VIR Buy
  • TIXT Hold
  • Analyst Count
  • VIR 5
  • TIXT 9
  • Target Price
  • VIR $36.40
  • TIXT $5.78
  • AVG Volume (30 Days)
  • VIR 1.1M
  • TIXT 283.9K
  • Earning Date
  • VIR 10-31-2024
  • TIXT 11-08-2024
  • Dividend Yield
  • VIR N/A
  • TIXT N/A
  • EPS Growth
  • VIR N/A
  • TIXT N/A
  • EPS
  • VIR N/A
  • TIXT 0.09
  • Revenue
  • VIR $78,618,000.00
  • TIXT $2,664,000,000.00
  • Revenue This Year
  • VIR N/A
  • TIXT N/A
  • Revenue Next Year
  • VIR N/A
  • TIXT $2.80
  • P/E Ratio
  • VIR N/A
  • TIXT $40.45
  • Revenue Growth
  • VIR N/A
  • TIXT 2.54
  • 52 Week Low
  • VIR $7.12
  • TIXT $2.83
  • 52 Week High
  • VIR $13.09
  • TIXT $11.51
  • Technical
  • Relative Strength Index (RSI)
  • VIR 73.82
  • TIXT 55.08
  • Support Level
  • VIR $7.12
  • TIXT $3.76
  • Resistance Level
  • VIR $9.74
  • TIXT $3.90
  • Average True Range (ATR)
  • VIR 0.43
  • TIXT 0.13
  • MACD
  • VIR 0.19
  • TIXT 0.01
  • Stochastic Oscillator
  • VIR 83.21
  • TIXT 72.22

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares

TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.

Share on Social Networks: